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Abstract 
In this study, the interaction between the human proteins ABH3 and HRAD51, which are the 
human homologs of the E.coli proteins AlkB and RecA respectively, is analysed. The proteins, 
which are His-tagged are purified using E.coli expression system. The interaction between the 
proteins is analyzed using FPLC system. Even though the bacterial proteins have been shown to 
interact, the same could not be shown for the human homologs in this study. 
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Chapter 1 
Introduction 
1.1 DNA damaging alkylating agents are cytotoxic:  
Every cell’s genome is continuously get exposed to various environmental 
and endogenously generated DNA damaging alkylating agents. Major 
sources of internal alkylating agents are from the cellular methyl donors 
such as S-adenosylmetionine (SAM), a common cofactor of biochemical 
reactions or the by-products of oxidative damage (1-3). Cancer 
chemotherapy also uses some of the alkylating agents (4). Methylmethane 
sulfonate (MMS) is a potential alkylating agent which is normally used in 
experimental methylation of nucleic acids. MMS methylates double-
stranded DNA and generate 7-methylguanine (7meG) and 3-methyladenine 
(3meA) (5). These block the DNA replication and are considered to be a 
lethal lesion. MMS also methylates single-stranded DNA and generates 
1-methyladenine (1meA) and 3-methylcytosine (3meC) (6). ABH3 proteins 
belong to the alpha-ketoglutarate- and Fe(II)-dependent dioxygenase 
superfamily and repair 1meA, 3meC, 3meT, and 1meG by oxidative 
demethylation.  
1.2     E. coli AlkB repairs methylation damage: 
The E. coli AlkB protein eliminates damaged DNA by mechanism of 
oxidative dealkylation of N1-methyladenine or N3-methylcytosine DNA 
lesions (7). AlkB and hABH3 are found to remove 1-meA and 3-meC from 
RNA, suggesting that cellular DNA repair can occur failure of which leads 
to cell death in both E. coli [8] and human cells [9]. Comparative structural 
analysis of the AlkB with no ligand and AlkB with ssDNA having 1-meG 
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(PDB IDs: 3KHB and 3KHC, respectively) unveils many fascinating 
mechanistic details (10). The protein utilizes both hydrophobic interactions 
and hydrogen bonding, and spreads over five nucleotides to maintain the 
protein-DNA complex. The phosphodiester backbone of ssDNA binds within 
the DNA binding groove (electropositive) created by Thr 51, Tyr 55, Ser 
129, and Lys 127 positions. This helps in the flipping of alkyl-lesions into 
the substrate binding center of the AlkB protein where the metal binding 
residues (His 131, Asp 133, and His 187) and substrate binding residues 
come close to each other. The base substrate binds in the active site patch 
formed by non-polar stacking interaction of Trp 69 and His 131 (10). These 
interactions help to stabilize the flipped conformation of 1meG in substrate 
binding center. It guides to the proper positioning of the methyl group of 
the 1-meG adjacent to the bound metal ion for oxidative repair. The 
common interactions between the amino acid residues of AlkB protein and 
the phosphodiester backbone or methylated base of the nucleotide does not 
distinguish between ribonucleotide and deoxyribonucleotide substrates, 
which explains the capability of AlkB to function on both RNA and DNA 
(10). Another crystal structures of trinucleotide substrate containing 1meA 
and E. coli AlkB complex also reveals several details of the catalytic site. 
The nucleotide backbone is bound in a cooperative hydrogen bonding (H-
bonding) network in which the two phosphates 5’ to the alkylated adenine 
base interact with Thr 51, Tyr 76 and Arg 161. The first two residues are 
located in flexible segments of the nucleotide-recognition lid, whereas Arg 
161 comes from a flexible surface loop comprising residues 159–164 in the 
dioxygenase core. The centre of the H-bonding network is Tyr 76, which 
forms a bidentate H-bond bridging the two phosphates. Arg 161 makes a 
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salt bridge to the 5’phosphate of the alkylated adenosine explaining the 
importance of this phosphate for substrate affinity. However, there are no 
other salt bridges to the trinucleotide, and the substrate binding pocket 
does not carry significant net charge. The alkylated 1-methyladenine base is 
bound in a deep, predominantly hydrophobic cavity, where it is sandwiched 
between invariant residues Trp 69 from the nucleotide-recognition lid and 
His 131, an Fe-ligating residue in the dioxygenase core.  
1.3  Structure of E. coli ABH3 reveals molecular mechanism of 
DNA repair: 
ABH3 is 286 amino acid long protein and is a structural member of the 
Fe(II)/2OG-dependent dioxygenase superfamily (11) . ABH3 couples with 
DNA demethylation to conversion of 2OG into succinate, formaldehyde and 
CO2. ABH3 catalytic activity is important for alkylation damage resistance 
(12). From the biochemical experiments it was found that ABH3 prefers 
dsDNA as substrates. It demethylates 1meA and 3meC in RNA (13). 
ABH3, like E. coli AlkB, is specific for SS DNA and RNA (14). The crystal 
structures of ABH3 is a beta-strand jelly-roll fold that coordinates a 
catalytically active iron centre using a highly conserved His1-X-Asp/Glu-
Xn-His2 motif (12).  A striking feature of hABH3 is three negatively 
charged residues (Glu123, Asp189 and Asp194) strategically located at the 
entrance of the DNA/RNA-binding groove and absent in AlkB. ALKBH3 
gene silencing induced cell cycle arrest at the G1 phase. As a result 
inhibition of cell growth is observed (15). hABH3 targets genes that are 
undergoing transcription  and thus maintains nuclear single-stranded DNA 
and RNA. 
1.4 AlkB interacts with RecA:  
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The E. coli RecA protein is a 352 amino acid long polypeptide and have 
essential role in recombination. The structure of RecA protein has one large 
core domain, and two smaller domains at the N- and C-termini (16-18). In 
the active RecA filament, ATP is bound at the subunit-subunit interface 
(19). RecA protein binds to the single-stranded DNA with one RecA 
monomer for every three bases of DNA and forms nucleoprotein filament 
accompanied by ATP hydrolysis. This RecA filaments promote alignment 
with a homologous duplex DNA, strand exchange and branch migration 
(10). Beside nucleoprotein filament formation, RecA also has coprotease 
activity, which facilitates the autocatalytic cleavage of the LexA repressor. 
LexA is the repressor of many DNA damage-inducible genes, including recA 
and cleavage of LexA repressor promote induction of many lexA regulated 
genes. This response to DNA damage is known as SOS response (20). RecA 
also directly facilitate replicative bypass of DNA lesions by associating with 
DNA polymerase-V (pol-V) during SOS response (21). It has been 
experimentally found that AlkB prefers damaged ssDNA over undamaged 
ssDNA as a substrate (22) and AlkB identifies alkylated base lesions by 
scanning the genome (23). To gain a more complete understanding of the 
mechanism of recruitment of AlkB, we purified AlkB and performed a 
targeted proteomic analysis of proteins co-purified with AlkB protein using 
mass spectrometry (Unpublished observation). We found that AlkB 
physically interacts with the N-terminal domain of recombination repair 
factor RecA. RecA protein is found in all organism and essential for genetic 
recombination and recombinational DNA repair (24,25). At present, 
functional significance of RecA-AlkB interaction is not clear. 
1.5 hRAD51: 
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hRAD51 is the major eukaryotic homologous recombinase and it is 
necessary for the repair of DNA damage and the maintenance of genomic 
diversity and stability.  hRAD51 and hRAD54 proteins are the members of 
the RAD52 group (26) and hRAD51 is the homolog of Escherichia coli 
recombinase enzyme Rec A (27). From the alignments of the RecA and 
Rad51 protein sequences it was found that (11,12) RecA has a C-terminal 
extension whereas in Rad51 it was absent and that the Rad51 proteins have 
an N-terminal extension that is absent in RecA. The hRAD51 has shorter 
N-terminal extension as compared to Saccharomyces cerevisiae Rad51 
(ScRad51). It was reported that the N-terminal domain of hRad51 binds 
both single-stranded DNA (ssDNA) and dsDNA (28) whereas the C-
terminal domain of RecA binds double-stranded DNA (dsDNA) (29). 
hRAD51 protein has cellular DNA repair which restrict HIV-1 integration 
both in vitro and in vivo. In vitro it was found that the chemical activation 
of hRAD51 enhance its integration inhibitory properties, whereas inhibition 
of hRAD51 decreases the integration restriction. This indicate that 
hRAD51 recombinase activity results in the modulation of HIV-1 
integration (30). Cellular analyses demonstrated that cells exhibiting high 
hRAD51 levels prior to de novo infection are more resistant to integration. 
On the other hand, when hRAD51 was activated during integration, cells 
were more permissive. The human RAD51 (hRAD51) protein plays a major 
role in homologous recombination (HR) DNA repair and was previously 
shown to interact with HIV-1 integrase (IN) and inhibit its activity (31). In 
the RecA/RAD51 domain, two highly conserved consensus motifs are found 
namely Walker A and Walker B, which are present in ATPases and confer 
ATP binding and hydrolysis activities (32). 
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N -terminal domain of RecA is similar to that of Rad51: The RecA 
NTD contains only a helix (residues 1–23) and a β-loop (residues 24–33). 
By contrast, the NTDs of archaeal and eukaryotic RecA family proteins are 
composed of two helix-hairpin-helix (HhH) motifs. It has been reported that 
the α-helix of the RecA NTD (residues 1–23) shows significant amino acid 
sequence conservation with the second HhH motif of archaeal and 
eukaryotic RecA family proteins. First, Gly15 and Lys23 of RecA are 
conserved in all RecA family members. The equivalent respective residues 
in human Rad51 are Gly65 and Lys73. Second, Lys8 of E. coli RecA also 
conserved in eukaryotic Rad51 and Dmc1 proteins. The positively charged 
side chains of Lys8, Lys19, and Lys23 all point outward to the outermost 
surface of the active RecA-ssDNA presynaptic nucleoprotein filament. 
Intriguingly, these three lysine residues are conserved among most, if not 
all, prokaryotic RecA proteins. Third, Glu18 of RecA is also conserved in 
several other RecA family proteins.  
Objectives: Since we have strong evidence to prove that purified AlkB and 
RecA forms stable complex whereby RecA enhances AlkB-catalyzed repair 
of methyl ssDNA adducts, we wanted to examine is similar interaction also 
exists between the eukaryotic homolog of hRad51 and ABH3. 
The main objectives of the study are: 
1. Cloning, expression and purification of His-hRAD51, 
2. Interaction study of Tpa1 and hRad51 in-vitro. 
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Chapter 2 
M aterials and M ethods 
2.1 General Techniques 
2.1.1 Agarose gel electrophoresis:  
Horizontal agarose gel (0.6-1.2%) electrophoresis were routinely 
performed for separation of DNA fragments of various lengths (between 
100bp-10kb). Appropriate amount of agarose (SeaKem®LE, LONZA, 
Cat. no. 50005) was dissolved in 1X TAE buffer (40mM Tris-acetate; 
1mM EDTA pH 8.0) by heating in microwave oven. After cooling, 
ethidium bromide of concentration 1μg/ml was added into the gel 
solution and then poured into a mould and a comb was inserted to 
generate wells. After 30-45 minutes, when the gel got solidified 
completely, gel was mounted into electrophoresis chamber containing 1X 
TAE (40mM Tris-acetate; 1mM EDTA pH 8.0) and comb was removed 
gently. DNA samples and size marker were mixed with appropriate 
volume of 6X DNA loading dye (6x stock: 0.25% bromophenol blue; 0.25 
xylene cyanol FF; 30% v/v glycerol (Thermo Scientific, Cat. No. R0611). 
Electrophoresis were generally carried out at 60-120 volt till the xylene 
cyanol dye migrated to distance of half of the gel. DNA bands were 
visualized in gel documentation system from SynGene (Model no: Chemi 
XR5, S.No DR4V2/2355). DNA ladder of 1kb (Cat no: SM0311 Thermo 
scientific) was used for HRAD51, AlkB, ABH3, ABH2 and linearized 
plasmid DNA for fragment size determination.  
2.1.2 Preparation of competent E. coli cells:  
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Competent E. coli cells of DH5α and BL21 (DE3) pLysS were prepared 
as described by Alexander by using MnCl2 and CaCl2. 20μl of E. coli 
strains (DH5α and BL21 (DE3)pLysS) were taken from frozen glycerol 
stock and inoculated in 3ml of LB medium containing no antibiotics and 
incubated for overnight in a shaking incubator at 200 rpm. 1ml of this 
overnight grown culture was inoculated in a pre-warmed 100 ml of LB 
medium (1% tryptone, 0.5% yeast extract) prepared in 250ml Erlenmeyer 
flask. Inoculated culture was grown for about 4h at 30°C at 200 rpm in 
shaking incubator and the culture growth was monitored by measuring 
OD600 spectrophotometer every 20 minutes. When culture had reached 
OD600 of ~0.35 it was taken out and incubated on ice for 1hr. Cells were 
harvested in two sets by centrifugation at 4000 rpm for 15 min at 4°C. 
The supernatant was discarded and the cell pellets were resuspended in 
12ml of acid salt buffer-A (ASB-A, sodium acetate- 40mM, CaCl2- 
100mM, MnCl2- 70mM, pH 5.5) and incubated on ice for 1 hour. Then 
solution from both the falcon tube were combined in one falcon tube and 
the ASB treated cells were then pelleted by centrifugation carried out at 
3500 rpm for 15 min at 4°C and resuspended in 2ml of ASB-B (Sodium 
acetate- 40mM, CaCl2- 100mM, MnCl2- 70mM, 15% glycerol, pH 5.5) 
and were stored in Eppendorf tubes (aliquots of 50μl) in deep freezer at -
86 °C for future use.  
2.1.3 Purification of DNA from agarose gels (gel extraction):  
DNA was purified from agarose gels using GeneJET gel extraction kit 
(Fermentas Life Sciences, cat. No. K0691) following the instructions 
recommended by the manufacturer.  
2.1.4 Restriction digests and Ligation:  
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All restriction enzymes were purchased from New England Biolabs and 
used according to the manufacturer’s instructions. Ligation reactions 
were performed using T4-DNA ligase (New England Biolabs), used as 
recommended by the manufacturer. Whole ligation reactions were used 
for transformation into E. coli (DH5α).  
2.1.5 Plasmid DNA Isolation from mini bacterial culture:  
A single colony was picked out from the plate containing colonies of 
DH5α transformed cells and inoculated in 2ml of LB medium containing 
ampicillin. The culture was incubated in a shaking incubator at 37°C, 
200 rpm for overnight. Entire culture was used for isolation of plasmid 
DNA using Plasmid Mini-Prep kit (Fermentas Life Sciences, cat. No. 
K0502) following the instructions recommended by the manufacturer.  
2.1.6 Transformation of competent E. coli cells:  
(I) Transformation of competent DH5α  cells : DH5α competent E. 
coli cells were prepared as described above. 5μl of a ligation mixture was 
added to 25μl of competent DH5α cells and incubated on ice for 30 
minutes. After that heat shock was given at 42°C for 30 seconds, cells 
were again briefly incubated on ice for 5 minutes and transformed 
competent cells were plated on LB- agar plates containing 100μg/ml 
ampicillin. Plates were incubated at 37°C overnight.  
(II) Transformation of competent BL21 (DE3) pLysS cells: 
BL21(DE3)pLysS competent E. coli cells were prepared as described 
above. 1μl of a plasmid DNA was added to 20μl of competent cells and 
the mixture was incubated on ice for 5 minutes. After a 42°C heat shock 
for 30 seconds, the cells were briefly incubated on ice for 5 minutes. After 
this incubation, entire transformation mixture was plated on LB-agar 
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plates containing 100μg/ml ampicillin. Plates were incubated at 37°C 
overnight for growth of cells.  
2.1.7 SDS-PAGE:  
Recombinant proteins were analyzed through SDS-PAGE. SDS-PAGE 
was carried out using discontinuous buffer system as described by 
Laemmli using Bio-Rad gel electrophoresis apparatus (Cat. no: 165-
8001). Throughout this study 1.5mm thick 10% and 12% polyacrylamide 
(30:0.8 acrylamide to bisacrylamide ratio) gel containing 0.1% SDS was 
used for electrophoretic separation of proteins. The protein samples were 
mixed with half volume of 3X sample buffer (2.4ml 1M Tris-HCl, pH 6.5; 
3ml 20% SDS, 3ml 100% Glycerol, 1.6ml β-mercaptoethanol, 0.006g 
Bromophenol blue) and heated at 100°C for 10 minutes and were loaded 
into the wells of precast polyacrylamide gel. Electrophoresis was 
performed at a constant voltage range of 100-140V by diluting 10x buffer 
(Tris base 30.3g, Glycine 144g, SDS 10g in 1000ml). After the 
electrophoresis, the gel was stained with Coomassie brilliant blue (0.4% 
w/v Coomassie blue R250, 30% v/v Methanol, 10 % Acetic acid). 
Spectra multicolor broad range protein ladder was used to confirm the 
size of protein. Composition of 10% and 12% SDS-PAGE gel is given 
below:  
 
 
 
SDS-PAGE Gel Composition 
Resolving Gel Stacking Gel 
Components 10% 12% Components 4% 
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30% Acrylamide 
bisacrylamide 
1.65
ml 
2.0ml 
30% Acrylamide 
bisacrylamide 
0.65 
ml 
Tris-HCl, pH 8.8, 1.5M 
1.25
ml 
1.25
ml 
Tris-HCl, pH 6.8, 0.5M 
1.25 
ml 
H2O 
2.05
ml 
1.70
ml 
H2O 
3.05 
ml 
SDS (10%) 
50.0
l 
50.0
l 
SDS (10%) 50l 
APS 
45.0
l 
45.0
l 
APS 25 l 
TEMED 
20.0
l 
20.0
l 
TEMED 10.0l 
 
2.1.8 M edia and Solutions:  
De-ionized water was used for all buffers solutions and media. 
2.1.9 Other solutions: 
i) Isopropyl β -D-1-thiogalactopyranoside (1M ): IPTG 4.7g, 
H2O 20ml. 
ii) 20% SDS: SDS (20g), H2O (80ml). Make final volume 100 ml 
with stirring. 
iii) 20% Ammonium per Sulfate:  APS (0.2g), H2O (0.8 ml).  
2.1.10 General buffers used in the study: 
Buffers Composition 
 TE (Tris-EDTA) 50X 
1mM Tris-HCl pH 8.0, 0.1 mM EDTA pH 
8.0. A 10X stock solution was routinely used 
to prepare 1X TE. 
SDS-PAGE Resolving gel 
buffer 
1.5 M Tris-HCl, (for Resolving Gel) ,pH 8.8 
M edia Composition 
LB media 1%Tryptone w/v,  0.5% w/v Yeast Extract 
TB media 
1.2% Tryptone w/v, 2.4% Yeast Extract, 0.4% v/v 
glycerol 
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SDS -PAGE Stacking gel 
buffer 
0.5 M Tris-HCl (for stacking gel), pH 6.5 
10X SDS-PAGE gel 
running buffer 
Tris base 30.3g, Glycine 144g, SDS 10g (add 
last) , 
Make final volume to 1000ml. 
1X Gradient gel running 
buffer 
25mM Tris Base, 192mM Glycine, 0.1 % 
(w/v) SDS, methanol 20%. 
3X SDS-PAGE loading dye 
(10ml) 
 
1M Tris-Cl, pH 6.5 (2.4 ml), 20% SDS (3 
ml), Glycerol (100%) (3 ml), -
mercaptoethanol (1.6 ml), Bromophenol blue 
(0.006g). 
SDS-PAGE staining 
solution. 
Coomassie blue R250-0.4% w/v, Methanol-
30% v/v, Acetic acid 10%v/v 
SDS-PAGE de-staining 
solution 
Methanol- 30 % v/v, Acetic acid 10 %v/v. 
 
2.2 Cloning of H is-hRAD51 
2.2.1 PCR amplification of hRAD51: 
The genomic DNA isolated from E. coli K-12 strain was used as template 
to amplify the HRAD51 gene fragment. The PCR was carried out using 
Phusion High- Fidelity Polymerase (Cat. No: M0530S). The gene 
sequence was retrieved from NCBI and forward and reverse primers were 
designed accordingly. The primers hRAD51-BamHI-Sen 
(5’AAAAGGATCCATGGCAATGCAGATGCAGCTTG3’) and 
hRAD51-SalI-Anti 
(5’AAAAGTCGACTCAGTCTTTGGCATCTCCCAC3’) were 
synthesized by Imperial Life Sciences, Haryana, India. hRAD51 gene was 
amplified using the specified primers. The PCR reaction had dNTP- 200 
μM, primers-1.0 μM each and enzyme 1 unit. The PCR condition for 
amplification was as follows: Initial denaturation: 98 ̊C for 30 seconds: 
followed by 98 ̊C for30 seconds: 56 ̊C for 30 seconds: 72 ̊C for 1 min: final 
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extension 72 ̊C for 10 min: and 4 ̊C on hold. PCR was carried out for 32 
cycles of amplification. The product was checked in 0.8 % agarose gel, 
run in 1X TE-buffer, pH 8.0 (10 mM Tris, 1 mM EDTA) at 120 V for 15 
min. Standard 1kb DNA ladder (NEB) was used to compare the size of 
the amplicon. After the run, the gel was viewed under SynGene Gel Doc 
system. 
2.2.2 Restriction digestion of PCR product: 
The PCR product was cleaned-up using Gene-Jet PCR clean-up kit 
(Cat.no: #K0701). Reaction conditions for the restriction digestion were 
as follows: Cleaned-up PCR DNA - 44 μl, 10X NEB buffer 4- 5.0 μl, 
BamHI-0.5 U, SalI-0.5 U, incubated overnight at 37 ̊C. The entire 
digested product was analyzed by 0.8 % agarose gel at 80 V for 20 min. 
After completion of the run, the digested PCR product was seen under 
transilluminator and the gel was cut with a sterile scalpel. The digested 
product was extracted from the gel using GeneJET Gel extraction kit 
(Thermo Scientific: #K0691). The product was eluted in molecular grade 
water. The eluted product was analyzed in 0.8 % agarose gel run at 120 
V for 15 min. 
2.2.3  Restriction digestion of vector: 
For cloning of HRAD51 gene, pRSET-A (GE Healthcare), a vector with 
N-terminal polyhistidine tag was used. Vector digestion was carried out 
with plasmid DNA- 17.0 μl, 10X NEB buffer 4- 2.0 μl, BamHI-0.5 U, 
SalI-0.5 U and incubated overnight at 37 ̊C. The digested product was 
separated in 0.8 % agarose gel at 80 V for 20 min. To visualize the 
linearized plasmid DNA, the gel was exposed under transilluminator and 
the band was cut using a scalpel. The DNA was extracted from the gel 
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plug using GeneJET Gel extraction kit (Thermo Scientific: #K0691). 
The eluted product was analyzed in a 0.8 % agarose gel. 
2.2.4 Ligation of BamHI, SalI digested HRAD51 and pRSET-A: 
Ligation of BamHI, SalI digested hRAD51 and pET28a was carried out 
using T4- DNA ligase (NEB: M0202). The composition of the ligation 
was as follows: BamHI, SalI cut HRAD51 (insert) 7.0 μl, BamHI, SalI cut 
pET28a (vector) - 1.0 μl in a 10.0 μl reaction. The ligation reaction was 
incubated at 16 ̊ C for 17 h. 
2.2.5 Transformation of ligation and colony screening: 
The ligation mixture after incubation was transformed into DH5α 
competent cell. Entire 10.0 μl of the ligation mix was added to 50 μl 
DH5α competent cells and incubated on ice for 30 min. The incubation 
was followed by heat shock at 42 ̊C for 30 sec. After incubation on ice for 
5 min, entire transformation mix was plated on LB-agar plate (Tryptone-
1 %: Yeast extract- 0.5 %: agar-1.5 %) containing Ampicillin (final conc. 
100 μg/ml). The plates were incubated at 37 ̊C for 12 h. 
Isolated single colonies obtained after the transformation were 
inoculated into 2 ml LB-Kan broth and incubated at 37 ̊ C / 200 rpm / 
13 h. The colonies obtained were screened using GeneJET plasmid 
purification kit (Thermo Scientific, Cat.no: #K0502) as per instruction. 
The plasmid DNA thus obtained was analyzed on 0.8 % agarose gel, run 
at 120 V for 20 min. 
2.2.6 Confirmation of the clones: 
Plasmids containing insert were initially selected based on the slower 
mobility in the agarose gel analysis. These clones were further confirmed 
for the presence of insert and orientation of the insert by restriction 
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analysis. One restriction site (PvuII) was chosen that is present in both 
the vector backbone and the gene of interest. In a ligated vector the 
position of PvuII are 457 and 758 nucleotide and the presence of correct 
insert would result in release of an insert of size 302 nucleotide. The 
reaction conditions were as follows: Plasmid DNA: 5.0 μl, PvuII- 1.0 U, 
in a total volume of 10 μl. The reaction was incubated at 37 ̊C for 4 h 
and 10 μl of the reaction was then analyzed in 0.8 % agarose gel run at 
120 V / 20 min. 
2.3  Expression of recombinant HRAD51: 
2.3.1 Transformation of pRSETA-HRAD51 into 
BL21(DE3)pLysS 
The positive clones, after restriction analysis, were selected for 
transformation into bacterial expression system, BL21 (pLysS). 1.0 μl of 
plasmid DNA was added to 50 μl of BL21 (DE3) pLysS competent cells 
and the transformation mix was incubated on ice for 5 min. Heat shock 
was given at 42 ̊C for 30 sec. After incubation on ice for 5 min., entire 
transformation mix was plated on LB-Kan agar plates. The plates were 
then incubated at 37 ̊C for 12 h. 
2.3.2  Small-scale expression analysis of recombinant H is-
hRAD51 
After the transformation, 5-10 colonies were inoculated into 5 ml of LB-
Kan broth. Cells were allowed to grow till log phase (approximately 3 h) 
at 37 ̊C, 200 rpm. 2 ml of the culture was aliquoted as uninduced sample 
and the remaining 3 ml was induced with 1 mM Isopropyl β-D-
thiogalactoside (IPTG, Sigma I6758). Induction was carried out at 30 ̊C 
for 4 h. After the induction, 1 ml of uninduced and 750 μl of induced 
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cells were pelleted at 8000 rpm for 5 min. Pellet was then resuspended in 
200 μl of Protein Extraction Buffer (Tris, pH 8.0 - 50 mM; NaCl - 250 
mM; Triton X – 0.005 %) followed by incubation on ice for 5 min. 40 μl 
of resuspended cells were mixed with 20 μl of 3X SDS-loading dye (Tris, 
pH 6.5 – 250 mM; SDS – 6 %; Glycerol – 30 %; β-mercapto ethanol – 
2.28 M; Bromophenol blue – 0.06 %). The sample thus prepared was 
incubated in dry bath at 100 ̊C for 10 min. 15 μl of the uninduced and 10 
μl of the induced samples were loaded into 10 % SDS-PAGE, run at 140 
V for 50 min. Prestained protein ladder (Fermentas, Cat No.: PMT2522) 
was used as the molecular weight standard. SDS-PAGE gel was stained 
with staining solution (Coomassie brilliant blue R250 Sigma, CatB7920 – 
0.4 %; Methanol – 30 %; Acetic acid – 10 %) for 20 min. Excess stain 
was removed by destaining solution (30 % Methanol, 10 % Acetic acid) 
in several steps. 
2.4 Purification of recombinant hRAD51 
2.4.1 Large scale culture of recombinant hRAD51 
The positive clone(s) for expression was inoculated into 100 ml LB-Kan 
broth and grown overnight at 37 ̊C / 200 rpm. The preinoculum was 
then diluted into 1 L Terrific Broth (Tryptone – 1.2 %; Yeast extract – 
2.4 %; Glycerol – 0.4 %). The culture was grown till mid-log phase at 
37 ̊C / 200 rpm / 3 h using incubator shaker (JSR, Model No. JJSI-
100C). The culture was then induced with 1 M IPTG (Sigma, Cat. No. 
I6758) (final concentration 1 mM). Induction was carried out at 30 ̊C / 
200 rpm / 4 h 30 min. Cells were then pelleted at 8000 rpm / 15 min / 
4 ̊C using centrifuge (Thermo Scientific, Model No. SORVALL Legend 
17 
XTR). Pellet was stored at -80 ̊C refrigerator (Thermo Fischer 
Scientific, Model No. FORMA 900 Series). 
2.4.2  Purification of recombinant hRAD51 protein by N i-NTA 
affinity 
The cell pellet was resuspended in 20 ml of extraction buffer (Tris, pH 
8.0 – 50 mM; NaCl 300 mM; Triton X100 0.1 %; Imidazole – 1 mM) by 
vortex. Total extract was then subjected to sonication on ice for 15 min 
with pulse 10 sec on and 10 sec off, at 25 % amplitude using a sonicator 
(Sonics Vibra Cell, Model No. VCX 130, Frequency- 20 kHz). Cell debris 
were pelleted at 14000 rpm / 20 min / 4 ̊C using centrifuge (Thermo 
Scientific, Model No. SORVALL Legend XTR). Clear supernatant was 
taken for Ni-NTA (Qiagen, Cat. No. 30210) bead binding. Before 
addition of the beads to supernatant, beads were equilibrated with the 
extraction buffer. Binding was carried out by gentle rotation at 10 rpm / 
4 ̊C for 4 h. After binding unbound fraction was removed by 
centrifugation at 1000 g / 4 ̊C / 5 min using refrigerated microcentrifuge 
(Thermo Scientific, Model No. SORVALL Legend XTR). Protein bound 
beads were then washed 3 times with wash buffer (Tris, pH 8.0 – 50mM; 
NaCl 350 mM; Triton X100 0.1 %; Imidazole – 5 mM). Washing step was 
repeated 3 times with 15 ml wash buffer. The bound protein was eluted 
using elution buffer (Tris – 10 mM; NaCl 100 mM; Imidazole – 250 mM). 
Protein was collected in 4 different fractions as elute – 1, 2, 3 and 4. The 
protein elutes along with soluble, insoluble, unbound and wash fractions 
were loaded and checked in 10 % SDS-PAGE at 140 V / 50 min. 
Prestained protein ladder (Fermentas, Cat No.: PMT2522) was used as 
the molecular weight standard. SDS-PAGE gel was stained with staining 
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solution (Coomassie brilliant blue R250 Sigma, CatB7920 – 0.4 %; 
Methanol – 30 %; Acetic acid – 10 %) for 20 min. Excess stain was 
removed by destaining solution (30 % Methanol, 10 % Acetic acid) in 
several steps. After destaining, the protein elutes, which has protein, 
were pooled together for dialysis against dialysis buffer (Tris 10 mM, 
NaCl 100 mM, Glycerol – 5 %) using dialysis membrane of molecular 
weight cut-off 3500 Da (Spectrum labs, Cat. No.: 132590 Spectra Por). 
The dialysis buffer was changed three times. After dialysis protein was 
aliquoted as 50 μl and 100 μl and stored at -80 ̊C. 
2.5 Analysis of RecA -AlkB interaction by size exclusion 
chromatography 
Samples of purified recombinant proteins were applied to Superose-12 
(GE Healthcare) gel filtration column and analyzed using an AKTA 
Prime FPLC system (GE Healthcare). For analysis of scRad51-Tpa1 
complex, 0.5 mg of Tpa1 was mixed with 0.5 mg of scRad51 in 0.5 ml 
buffer containing 25mM NaCl and 20mM HEPES, pH 7.0 or 20mM 
Tris-HCl, pH 8.0. The samples were analyzed with flow rate of 0.3 
ml/min and 0.5 ml fractions were collected.  
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Chapter 3 
Results 
3.1 Cloning, Expression and purification of hRad51:  
Full length hRad51 was PCR amplified and examined by 0.8% agarose gel 
electrophoresis. The expected PCR amplification of size 1020 bp was 
obtained (Figure 1A). The full length hRad51 PCR product and plasmid 
pET28 were sequentially digested by BamHI and SalI and ligated.  The 
clone was selected by slower mobility compared to negative control 
(pET28) (Figure 1B).  Sequencing was performed to finally confirm the 
clone. 
For recombinant protein expression, Escherichia coli BL21(DE3) cells were 
transformed with pET28-hRad51. These cells were grown and induced for 
protein expression by IPTG. Expression of the recombinant protein was 
confirmed by SDS-PAGE analysis in 12% gel and staining with Coomassie-
brilliant blue (Figure 2A). Since the proteins had the C-terminal his tag, 
they were purified by Ni-NTA affinity chromatography (Figure 2B).  
 
3.2 Purification of AlkBH3:  
AlkBH3 was cloned in pET28 vector by Ms Monisha Mohan (PhD student 
in Dr. Anindya Roy’s lab) (Figure 3A). The purity of the protein was 
checked by SDS-PAGE (Figure 3B). 
 
3.3 hRad51 does not interact with AlkBH3  
To examine if hRad51 forms stable complex with AlkBH3 or they interact 
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transiently, we analyzed their interaction by size exclusion chromatography 
(SEC). First, recombinant hRad51 and AlkBH3 purified from E.coli were 
applied separately to a Superose-12 SEC column equilibrated with 25 mM 
NaCl and 20 mM Tris-HCl, pH 8.0. Eluted fractions were applied to SDS-
PAGE to detect and identify the protein contents.  SEC analysis of hRad51 
(0.5 mg) showed that hRad51 protein was eluted predominantly near the 
void volume of the column (8 ml) (Fig 4B). This is probably due to 
existence of hRad51 as various oligomers in equilibrium. In the absence of 
DNA, hRad51 protein can self-assemble into a variety of multimeric forms, 
including rings, rods and highly aggregated structures. AlkBH3 protein was 
found in a distinct peak at an elution volume of ~13ml, which corresponds 
to a molecular mass of approximately 45 kDa (Fig 2A). This indicates that 
AlkBH3 purified from E. coli exists as a monomer. To elucidate 
characteristics of the AlkBH3-RecA protein complex, equal amount (0.5 
mg) of the proteins were mixed and assessed by SEC. The highest 
concentrations of hRad51 and AlkBH3 were eluted at 8ml and 13ml, 
respectively, indicating the individual proteins remained separate and there 
was no evidence of an interacting peak (Fig 4C).  
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Figure 1. Cloning of hRad51. A. The PCR amplification of hRad51 
gene was confirmed by running the sample on Agarose Gel. A band near 
1000 marks of ladder suggested the amplification of the gene as the length 
of the gene is 1020 bp B. Comparison of mobility of pET28a-scRad51 and 
pET28a. Slower mobility (lane 2) suggest the presence of insert. 1kb ladder 
was used to compare the size of PCR amplified product. The Gel was 
viewed under SynGene Gel Doc system. C. Plasmid map of pET28a-
hRad51 generated using SnapGene software. Unique restriction sites are 
indicated in bold.  
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Figure 2. Cloning and expression of hRad51. A. pET28-hRad51 was 
transformed into BL21 (DE3) pLysS and was analyzed for expression of 
His-ABH3 (50 kDa) by induction, using 1 mM IPTG. The expression level 
of the induced cell extract (lane 2) was compared with the uninduced cell 
extract (lane 1), analyzed in 10% SDS-PAGE. B. Recombinant His-hRad51 
was purified from 1 L culture by one-step Ni-NTA-affinity chromatography. 
Bacterial lysate (lane 1) was loaded along with Soluble (lane 2), and wash 
fraction (lane 3). The purified His-ABH3 (lane 4 and 5) was collected as 
different fractions. All the fractions were loaded in 10% SDS-PAGE along 
with Pre-stained Protein Marker (lane 6) and the bands were visualized by 
Coomassie staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Cloning and expression of AlkbH3.  A. Plasmid map of 
pET28a-AlkBH3 generated using SnapGene software. Unique restriction 
sites are indicated in bold. B. SDS-PAGE analysis of purified AlkBH3. 
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Figure 4. Analysis of hRad51 and AlkBH3 by SEC. 0.5 mg of hRad51 or 
AlkBH3 present in 20mM Tris-HCl, pH 8.0, 25mM NaCl analyzed by 
Superose-12 FPLC column. (A) AlkBH3 eluted as monomer. (B) Rad51 
eluted as high molecular weight aggregate. (C) RecA and AlkB were mixed 
together in the same buffer (mentioned above) and analyzed by SEC. No 
new peak was observed which is separate from hRad51 and AlkBH3 peaks.  
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